Master B12 and folate deficiency anemias, Schilling test, and megaloblastic changes for ASCP hematology MCQs.
Chapter 10 โ ANEMIAS CAUSED BY DEFECTS OF DNA METABOLISM
1 ยท Priority Table & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| CBC and blood film of megaloblastic anemia (MCV often >120, oval macrocytes, hypersegmented neutrophils, pancytopenia, โ retic) | HIGH | Case-based recognition โ the classic presentation |
| Hypersegmentation rule (โฅ5 five-lobed per 100 or 1 six-lobed; mean lobe count >3.4) | HIGH | Reporting rule and earliest morphologic sign |
| MMA vs homocysteine: Bโโ deficiency โ both; folate deficiency โ homocysteine only | HIGH | Most-tested biochemical distinction |
| Bโโ absorption pathway (haptocorrin, intrinsic factor, cubam, transcobalamin, holoTC) | HIGH | ‘Most metabolically active form’ = holotranscobalamin |
| Pernicious anemia: autoimmune, anti-IF (blocking) and anti-parietal cell antibodies, achlorhydria, โ gastrin | HIGH | Classic diagnosis questions |
| Megaloblastic marrow: nuclearโcytoplasmic asynchrony, M:E ~1:1, giant metamyelocytes and bands | HIGH | Morphology description items |
| Ineffective hematopoiesis โ โ indirect bilirubin and LDH | HIGH | Why megaloblastic anemia looks hemolytic |
| Folate trap and roles of Bโโ/folate in DNA synthesis | HIGH | Mechanism item |
| Neurologic symptoms only in Bโโ deficiency; folic acid masks the anemia but not the neuropathy | HIGH | Why the cause must be found before treatment |
| Macrocytic โ megaloblastic โ pernicious relationship; nonmegaloblastic causes | MEDIUM | Classification item |
| Causes of folate deficiency, drugs (methotrexate, phenytoin, trimethoprimโฆ), dialysis | MEDIUM | Risk group questions |
| Causes of Bโโ deficiency: vegans, food-cobalamin malabsorption, H. pylori, gastrectomy, D. latum, blind loop, Imerslund-Grรคsbeck | MEDIUM | Etiology matching |
| Diagnostic algorithms (Bโโ/folate cutoffs, pernicious anemia algorithm) | MEDIUM | Interpretation questions |
| False โ/โ in Bโโ and folate assays | MEDIUM | Pre-analytical interference |
| Response to treatment timeline | MEDIUM | Retic ~1 week, hypersegs gone in 2 weeks |
| Other megaloblastoid causes (MDS, erythroleukemia, CDA, reverse transcriptase inhibitors) | LOW | Differential only |
| Structural chemistry of cobalamin and folate, deoxyuridine suppression test | LOW | Rarely tested |
Focus: the CBC/film pattern, hypersegmentation rule, MMA vs homocysteine, Bโโ absorption (IF โ cubam โ transcobalamin โ holoTC), pernicious anemia tests, marrow asynchrony, and Bโโ vs folate differences (neurologic signs). Skim: cobalamin chemistry, folate structures, deoxyuridine suppression test, holoTC assay details.
Quick Foundation โ from zero
- Every dividing cell needs to copy its DNA. DNA needs thymidine, and making thymidine needs folate โ and folate needs vitamin Bโโ to be recycled into a usable form.
- If either vitamin is missing, DNA can’t be copied properly, but RNA and protein (hemoglobin) are still made. The nucleus lags behind the cytoplasm โ nuclearโcytoplasmic asynchrony โ big, immature-looking cells called megaloblasts.
- Many of these defective precursors die in the marrow (ineffective hematopoiesis), so all three cell lines fall (pancytopenia) and bilirubin and LDH rise.
- In blood: oval macrocytes (MCV often >120 fL) and hypersegmented neutrophils.
- Bโโ also protects nerves; Bโโ deficiency can cause neurologic damage even without anemia. Folate deficiency in early pregnancy causes neural tube defects.
- The most common cause of Bโโ deficiency from lack of intrinsic factor is pernicious anemia, an autoimmune attack on the stomach’s parietal cells.
DNA synthesis is a printing press and thymidine is the ink. Folate delivers the ink; Bโโ is the key that unlocks the ink cartridges (5-methyl THF). Without Bโโ, cartridges pile up locked (the folate trap). The press keeps running the cover (cytoplasm, hemoglobin) but the pages (DNA) come out half-printed โ oversized, unfinished books that get shredded in the warehouse (marrow) before shipping.
Giving folic acid to a Bโโ-deficient patient corrects the anemia but lets the nerve damage progress, possibly irreversibly. Correctly separating Bโโ from folate deficiency โ and finding the cause โ protects the patient.
| Concept | Plain-English Explanation |
|---|---|
| Macrocytic anemia | Anemia with MCV >100 fL (any cause) |
| Megaloblastic anemia | Macrocytic anemia caused by impaired DNA synthesis, with megaloblasts in the marrow |
| Pernicious anemia | Bโโ deficiency due to autoimmune loss of intrinsic factor โ one cause of megaloblastic anemia |
| Nuclearโcytoplasmic asynchrony | Cytoplasm matures (pinker) while the nucleus stays immature-looking |
| Ineffective hematopoiesis | Marrow is busy, but precursors die before leaving โ pancytopenia with a hypercellular marrow |
| Folate trap | Without Bโโ, folate is stuck as 5-methyl THF and can’t be recycled |
| Intrinsic factor (IF) | Stomach protein needed to absorb Bโโ in the ileum |
| Holotranscobalamin (holoTC) | Bโโ bound to transcobalamin โ the form cells can take up |
2 ยท Core Content Tables
2.1 Classification of Macrocytic Anemias (Rodak Box 21-1)
| Feature | Details |
|---|---|
| Relationship | Macrocytic โ megaloblastic โ pernicious anemia. Megaloblastic anemia is macrocytic, but not every macrocytic anemia is megaloblastic |
| Megaloblastic โ folate deficiency | Inadequate intake ยท increased need ยท impaired absorption (IBD) ยท impaired use due to drugs ยท excessive loss (renal dialysis) |
| Megaloblastic โ Bโโ deficiency | Inadequate intake ยท increased need ยท impaired absorption (failure to split from food or haptocorrin; lack of IF: pernicious anemia, H. pylori, gastrectomy, hereditary IF deficiency; general malabsorption; inherited transport errors: Imerslund-Grรคsbeck, transcobalamin deficiency) ยท competition (Diphyllobothrium latum, blind loop syndrome) |
| Other megaloblastosis | Myelodysplastic syndrome, acute erythroid leukemia, congenital dyserythropoietic anemia, reverse transcriptase inhibitors โ refractory to Bโโ/folate |
| Nonmegaloblastic macrocytic | Normal newborn, reticulocytosis, liver disease, chronic alcoholism, bone marrow failure |
2.2 Physiologic Roles of Vitamin Bโโ and Folate
| Feature | Details |
|---|---|
| Vitamin Bโโ (cobalamin) | Corrin (tetrapyrrole) ring + central cobalt + dimethylbenzimidazolyl ribonucleotide. Forms: hydroxy-, cyano- (food/supplements), methyl- and 5โฒ-deoxyadenosyl- (coenzyme forms) |
| Reaction 1 | Methylmalonyl CoA โ succinyl CoA by methylmalonyl CoA mutase (needs adenosylcobalamin). Bโโ deficiency โ โ methylmalonic acid (MMA) |
| Reaction 2 | 5-methyl THF + homocysteine โ THF + methionine by methionine synthase (needs methylcobalamin). This links Bโโ and folate |
| Folate | General term; folic acid = synthetic form. Pteridine ring + para-aminobenzoate + glutamate(s). Transfers one-carbon (methyl) units โ amino acid and nucleotide metabolism |
| Folate in plasma | Circulates mostly as 5-methyl THF, metabolically inactive until demethylated to THF (requires Bโโ) |
| DNA cycle | THF โ 5,10-methylene THF (serine โ glycine; serine hydroxymethyl transferase + Bโ) โ methyl donated to dUMP โ dTMP by thymidylate synthase โ DHF โ THF by dihydrofolate reductase. dTMP โ dTTP โ DNA |
| Polyglutamation | 1โ6 glutamates added in the cell โ needed to retain THF inside the cell |
2.3 Defect in Megaloblastic Anemia
| Feature | Details |
|---|---|
| Folate deficiency | Directly prevents methylation of dUMP โ โ thymidine |
| Bโโ deficiency | Indirect โ no THF from 5-methyl THF โ folate accumulates as 5-methyl THF (folate trap); some leaks out (not polyglutamated) โ โ intracellular folate |
| Both | Homocysteine accumulates (methionine synthase can’t work) |
| DNA damage | Uridine incorporated into DNA; repair fails without thymidine โ single-strand breaks โ coinciding excisions โ double-strand breaks โ DNA fragmentation |
| Cell fate | Division halted โ lysis or apoptosis of erythroid progenitors in the marrow = ineffective hematopoiesis; fewer RBCs released |
| Morphology | Surviving precursors are larger; nuclei have open, finely stippled, reticular chromatin (cell cycle delay, โ histones). RNA is unaffected (uses uracil), so cytoplasm matures normally โ nuclearโcytoplasmic asynchrony. All three lineages affected โ pancytopenia |
| Chemotherapy link (Box 21-2) | Methotrexate (higher affinity for dihydrofolate reductase than DHF) blocks the folate cycle; leucovorin rescue (folic acid derivative) counteracts it |
2.4 Other Causes of Megaloblastosis
| Feature | Details |
|---|---|
| Myelodysplastic syndrome | Megaloblastoid features plus cytoplasmic vacuoles, nuclear budding, multinucleation, fragmentation |
| Congenital dyserythropoietic anemia (CDA) | Types I and III; usually childhood. CDA I: internuclear chromatin bridging, binucleated forms. CDA III: giant multinucleated erythroblasts |
| Acute erythroid leukemia (FAB M6) | Macrocytic, megaloblast-like chromatin, โ myeloblasts |
| Reverse transcriptase inhibitors | HIV therapy interferes with DNA production |
| Key point | Due to mutations or DNA interference โ do not respond to Bโโ or folic acid |
2.5 Systemic Manifestations
| Feature | Details |
|---|---|
| Both deficiencies | Anemia symptoms (fatigue, weakness, dyspnea); alimentary tract: glossitis (smooth, sore tongue), gastritis, nausea, constipation |
| Bโโ deficiency only | Neurologic signs โ may occur without anemia: memory loss, numbness and tingling in toes and fingers, loss of balance, impaired walking, loss of vibratory sense (lower limbs), personality change, psychosis. Due to demyelination of spinal cord and peripheral nerves |
| Folate deficiency | Depression, peripheral neuropathy, psychosis reported; โ homocysteine โ possible cardiovascular risk (evidence mixed) |
| Pregnancy | Folate deficiency โ neural tube defects (spina bifida). U.S. FDA mandated folic acid fortification of grain/cereal (1998) |
| Blood picture | Indistinguishable between Bโโ and folate deficiency |
2.6 Causes of Folate vs Bโโ Deficiency
| Mechanism | Folate Deficiency | Vitamin Bโโ Deficiency |
|---|---|---|
| Sources | Leafy green vegetables, dried beans, liver, beef, fortified cereals, fruit (oranges). Heat labile โ overcooking destroys it | Animal products only: liver, dairy, fish, shellfish, eggs. Not made by plants. Not destroyed by cooking |
| Inadequate intake | Generally poor diet (alcoholism*) | Rare; strict vegans |
| Increased need | Pregnancy, lactation, infancy, childhood growth | Pregnancy, lactation, growth |
| Impaired absorption | Only ~50% of food folate absorbed (small intestine). Hereditary PCFT defect (AR). Tropical sprue, celiac disease (gluten), small bowel resection, IBD | See Bโโ absorption table below |
| Impaired use (drugs, Box 21-3) | Metabolism: methotrexate, 5-fluorouracil, hydroxyurea, pyrimethamine, pentamidine, phenytoin (anticonvulsants), trimethoprim. Absorption: metformin, cholestyramine | Long-term Hโ blockers and PPIs (โ acid) |
| Excessive loss | Renal dialysis (lost in dialysate) โ supplemented routinely | โ |
| Competition | โ | D. latum (fish tapeworm), blind loop bacterial overgrowth |
2.7 Vitamin Bโโ Absorption & Transport (Rodak Figure 21-5)
| Step | Where | What Happens |
|---|---|---|
| 1 | Stomach | Pepsin + HCl (acid) release Bโโ from food proteins |
| 2 | Stomach | Bโโ binds haptocorrin (R protein, transcobalamin I) from saliva |
| 3 | Stomach | Parietal cells secrete intrinsic factor (IF) (and Hโบ) |
| 4 | Duodenum | Pancreatic proteases (trypsin) digest haptocorrin โ free Bโโ binds IF |
| 5 | Ileum | IFโBโโ binds cubam (cubilinโamnionless) and megalin on ileal enterocytes |
| 6 | Enterocyte | Bโโ freed from IF, bound to transcobalamin (formerly transcobalamin II), released to portal blood |
| 7 | Plasma | Only 10โ30% of Bโโ on transcobalamin = holotranscobalamin (holoTC), the metabolically active form; ~75% on haptocorrins (TC I and III) |
| 8 | Cells | HoloTC binds TC receptors โ endocytosis. In pronormoblasts โ methylcobalamin. Hepatocytes store a substantial reserve or excrete via bile |
| Absorption Failure | Cause | Key Features |
|---|---|---|
| Failure to split from food | Food-cobalamin malabsorption: hypochlorhydria from atrophic gastritis (aging), long-term Hโ blockers/PPIs, gastric bypass | Common in elderly |
| Failure to split from haptocorrin | Lack of gastric acid or trypsin (chronic pancreatic disease) | Bโโ stays bound, excreted in stool |
| Lack of intrinsic factor | Pernicious anemia, H. pylori (parietal cell destruction), total/partial gastrectomy, hereditary IF deficiency (AR; normal gastric histology and acidity) | Most significant cause |
| General malabsorption | Celiac disease, tropical sprue, IBD | Also affects folate |
| Inherited transport errors | Imerslund-Grรคsbeck syndrome (cubilin or amnionless mutations, AR) ยท transcobalamin deficiency (AR) | Rare |
| Competition | Diphyllobothrium latum splits Bโโ from IF; blind loops with bacterial overgrowth | Stool for eggs/proglottids |
2.8 Pernicious Anemia
| Feature | Details |
|---|---|
| Definition | Autoimmune disorder โ impaired Bโโ absorption from lack of intrinsic factor; named because it was fatal before its cause was known |
| Epidemiology | ~25 new cases per 100,000 people >40 y per year; usually 6th decade or later (can occur in children); โ risk of gastric tumors |
| Mechanism | Pathologic CD4 T cells attack the Hโบ/Kโบ-ATPase of parietal cells โ chronic inflammation โ atrophic gastritis over years โ loss of Hโบ and IF |
| Achlorhydria | Loss of acid; previously a diagnostic criterion. Serum gastrin markedly โ |
| Antibodies | Anti-intrinsic factor (blocking) โ block the Bโโ-binding site; present in ~90% (serum or gastric fluid); highly specific, confirmatory (absence doesn’t rule out). Anti-parietal cell โ ~90%, nonspecific, not clinically useful for diagnosis |
| Schilling test | Former test of IF (24-h urine, radioactive cobalt) โ replaced by safer tests |
| Treatment | IM Bโโ (bypasses IF) or high-dose oral Bโโ; lifelong |
2.9 Screening Tests (CBC, Retic, Differential, Bilirubin, LDH)
| Feature | Details |
|---|---|
| Earliest sign | Slight macrocytosis |
| CBC | โ Hb, Hct, RBC; pancytopenia; Hb <7โ8 g/dL not unusual (slow onset). MCV 100โ150 fL, commonly >120 fL (iron deficiency, thal trait or inflammation can mask it). MCH โ, MCHC normal, RDW โ |
| Retic | Low absolute retic; no polychromasia |
| Blood film | Oval macrocytes, hypersegmented neutrophils, teardrop cells, RBC fragments, microspherocytes, schistocytes (can paradoxically lower MCV โ reflect dyserythropoiesis, not microangiopathy), nucleated RBCs, Howell-Jolly bodies, basophilic stippling, Cabot rings. Hct <20% โ megaloblastic nRBCs, occasional promegaloblast |
| Hypersegmentation | Essentially pathognomonic; appears early; persists up to 2 weeks after treatment. Report when โฅ5 five-lobed neutrophils per 100 WBCs or โฅ1 six-lobed; or mean lobe count (100 neutrophils) >3.4. Inexpensive, sensitive screen |
| Bilirubin & LDH | Intramedullary hemolysis (ineffective hematopoiesis) โ โ total and indirect bilirubin and โ LDH (mostly RBC-derived) |
- EDTA whole blood; make smears promptly โ prolonged EDTA storage can distort neutrophil nuclei (swelling, extra lobulation)
- Count lobes only when separated by a thin filament; overlapping lobes cause errors
- Analyzer MCV can rise with storage and with cold agglutinins โ rule out artifact
2.10 Bone Marrow Examination
| Feature | Details |
|---|---|
| Status | Reference confirmatory test for megaloblastic morphology but rarely needed now (invasive, expensive, doesn’t identify the cause) |
| Erythroid | Megaloblasts with nuclearโcytoplasmic asynchrony: cytoplasm matures (pinkish-blue), nucleus lags (open chromatin like a basophilic normoblast). Most striking at the polychromatic normoblast stage |
| Cellularity | Hypercellular; M:E โ 1:1 from erythroid hyperplasia โ but ineffective, so the blood shows pancytopenia |
| Myeloid | Larger than normal โ giant metamyelocytes and bands |
| Megakaryocytes | Inconsistent โ may be โ or โ, may show diminished lobulation |
2.11 Specific Diagnostic Tests
| Feature | Details |
|---|---|
| Serum Bโโ and folate | Immunoassay (Bโโ also competitive-binding chemiluminescence); many interferences โ reflex MMA/homocysteine improves accuracy |
| RBC folate | Stable (doesn’t fluctuate with diet), may reflect true status, but suboptimal sensitivity/specificity โ serum folate preferred initial test in the U.S. |
| Methylmalonic acid (MMA) | Serum or urine; โ in Bโโ deficiency (not folate). Also โ in renal impairment โ not definitive. Gas chromatographyโtandem mass spectrometry |
| Homocysteine | Plasma or serum; โ in both Bโโ and folate deficiency. Also โ in renal failure and dehydration. GC-MS, HPLC, fluorescence polarization immunoassay |
| Gastric analysis | pH โ achlorhydria (supportive, not diagnostic โ also with aging) |
| Serum gastrin | Markedly โ in pernicious anemia (immunoassay) |
| Antibodies | Anti-IF blocking antibody (specific, confirmatory); anti-parietal cell (IFA/ELISA; nonspecific) |
| Holotranscobalamin | Newer rapid immunoassays; specificity for Bโโ deficiency low โ routine use not supported; also โ in transcobalamin deficiency |
| Deoxyuridine suppression test | Deoxyuridine normally suppresses labeled thymidine incorporation; suppression abnormally low in Bโโ/folate deficiency; adding one vitamin identifies which โ impractical (marrow needed) |
| Stool for parasites | D. latum eggs/proglottids when Bโโ is low |
2.12 Causes of False Results in Bโโ and Folate Assays (Rodak Box 21-5)
| False โ Bโโ | False โ Bโโ | False โ Folate | False โ Folate |
|---|---|---|---|
| Assay technical failure ยท occult malignancy ยท alcoholic liver disease ยท renal disease ยท โ TC I and II binders (myeloproliferative states, hepatomas, fibrolamellar hepatic tumors) ยท activated TC IIโproducing macrophages (autoimmune disease, monoblastic leukemias, lymphomas) ยท release of cobalamin from hepatocytes (active liver disease) ยท high anti-IF antibody titer | Haptocorrin deficiency ยท folate deficiency ยท plasma cell myeloma ยท HIV ยท pregnancy ยท transcobalamin I deficiency ยท megadose vitamin C | Recent meal ยท alcoholism | Severe anorexia requiring hospitalization ยท acute alcohol consumption ยท normal pregnancy ยท anticonvulsant therapy |
- Fasting specimen for serum folate โ a recent meal falsely raises it (Rodak)
- Draw before any vitamin treatment or transfusion*
- Serum folate is light-sensitive โ protect from light*; hemolysis falsely raises serum folate (RBCs contain more)*
- Homocysteine: separate plasma promptly (RBCs keep releasing homocysteine at room temperature)*
- Interpret MMA and homocysteine with renal function โ both rise in renal failure
2.13 Laboratory Summary (Rodak Table 21-1)
| Test | Folate Deficiency | Vitamin Bโโ Deficiency |
|---|---|---|
| CBC | โ Hb, Hct, RBC, WBC, PLT; โ MCV, MCH | Same |
| Differential | Hypersegs, oval macrocytes, aniso-/poikilocytosis, inclusions | Same |
| Absolute retic | โ | โ |
| Total & indirect bilirubin, LDH | โ | โ |
| Bone marrow | Erythroid hyperplasia (ineffective), megaloblasts | Same |
| Serum Bโโ | N | โ |
| Serum folate | โ | N or โ |
| RBC folate | โ | N or โ (5-methyl THF leaks out without Bโโ) |
| MMA | N | โ |
| Homocysteine | โ | โ |
| Anti-IF/parietal cell antibodies | Absent | Present in pernicious anemia |
| Serum gastrin | N | Can be markedly โ in PA |
| Gastric analysis | N | Achlorhydria in PA |
| Holotranscobalamin | N | โ |
| Stool for parasites | Negative | D. latum may be the cause |
2.14 Macrocytic Nonmegaloblastic Anemias
| Feature | Details |
|---|---|
| Mechanism | DNA synthesis unimpaired |
| MCV | Mild: usually 100โ110 fL, rarely >120 fL |
| Film/marrow | No hypersegmented neutrophils, no oval macrocytes, no megaloblasts |
| Causes | Normal newborn, reticulocytosis (common), liver disease, chronic alcoholism, bone marrow failure |
2.15 Treatment & Response
| Feature | Details |
|---|---|
| Principle | Treat the specific deficiency and its cause (nutrition, treat D. latum) |
| Bโโ | IM for pernicious anemia (bypasses IF) or high-dose oral; lifelong in PA or malabsorption |
| Folate | Oral folic acid |
| Danger | Folic acid in Bโโ deficiency improves the anemia but doesn’t stop โ may worsen โ neurologic damage โ diagnose first |
| Iron | Often supplemented to support rapid cell production |
| Response | Marrow reverts toward normoblastic within hours ยท retic response ~1 week ยท Hb normal in ~3 weeks ยท hypersegs gone within 2 weeks ยท all parameters normal in 3โ6 weeks |
*From general hematology/laboratory practice, not stated in Rodak Ch. 21.
3 ยท Visual Memory Hooks
โAll Pernicious are Megaloblastic, all Megaloblastic are Macrocytic โ not the reverseโ.
โBโโ Bumps Both; Folate Flags only homocysteineโ.
โMutase Makes Succinyl; Synthase Supplies Methionineโ โ methylmalonyl CoA mutase and methionine synthase.
โNo Bโโ = locked Methyl-THFโ.
โAcid, R, IF, Trypsin, Cubam, TCโ โ acid releases; R protein binds; IF secreted; trypsin frees; cubam absorbs in ileum; transcobalamin carries.
โHolo = Whole, the one that Worksโ โ holotranscobalamin.
โ5 fives or 1 sixโ per 100 neutrophils; mean lobe count >3.4.
โOval, Over-segmented, Out of cells (pancytopenia)โ.
โOld coat, baby faceโ โ mature pink cytoplasm, immature nucleus (asynchrony); โGiant bandsโ.
โBusy marrow, empty blood, yellow skinโ โ M:E 1:1, pancytopenia, โ bilirubin/LDH.
โBโโ = Brain and nervesโ โ only Bโโ deficiency causes demyelination.
โIF is Identifying (specific); Parietal is Poor (nonspecific)โ.
โFolate = Foliage (heat kills it); Bโโ = Beasts (survives cooking)โ.
โMy Pals Try Fluoro-Hydroโ โ methotrexate, phenytoin/pyrimethamine/pentamidine, trimethoprim, 5-FU, hydroxyurea.
โHours, 1 week, 2 weeks, 3 weeksโ โ marrow, retics, hypersegs gone, Hb normal.
Pattern Triggers
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| MCV 121 fL, pancytopenia, โ retic, oval macrocytes, hypersegs | Megaloblastic anemia | Impaired DNA synthesis in all lineages |
| Above + โ indirect bilirubin and LDH | Ineffective hematopoiesis (intramedullary hemolysis) | Precursors die in marrow |
| Low Bโโ, โ MMA, โ homocysteine | Vitamin Bโโ deficiency | Mutase and methionine synthase both blocked |
| Low folate, normal MMA, โ homocysteine | Folate deficiency | Only methionine synthase pathway affected |
| Elderly man with neuropathy, macrocytic anemia, low Bโโ, โ MMA | Bโโ deficiency โ likely pernicious anemia | Demyelination + megaloblastic anemia |
| Low Bโโ + anti-IF blocking antibodies | Pernicious anemia | Specific, confirmatory |
| Low Bโโ, anti-IF negative, โ gastrin >200 pg/mL | Consistent with pernicious anemia | Achlorhydria raises gastrin |
| Strict vegan with megaloblastic anemia | Dietary Bโโ deficiency | Bโโ only in animal foods |
| Epileptic on phenytoin, macrocytic anemia | Drug-induced folate deficiency | Anticonvulsants impair folate metabolism |
| Low Bโโ in someone eating raw freshwater fish | Diphyllobothrium latum | Tapeworm competes for Bโโ |
| Macrocytosis 105 fL, no hypersegs, round macrocytes, alcohol history | Nonmegaloblastic (alcohol/liver) | DNA synthesis normal |
| Macrocytosis with โ retic and polychromasia | Reticulocytosis (nonmegaloblastic) | Retics are larger cells |
| Megaloblastoid marrow, normal Bโโ and folate, dysplasia | MDS, erythroleukemia or CDA | Refractory to vitamins |
| Iron deficiency + Bโโ deficiency together | MCV may be normal; RDW very high | Micro- and macrocytes average out |
Commonly Confused Pairs
| Feature | A | B |
|---|---|---|
| Megaloblastic vs nonmegaloblastic | MCV often >120; oval macrocytes; hypersegs; pancytopenia | MCV 100โ110; round macrocytes; no hypersegs |
| Bโโ vs folate deficiency | โ MMA; neurologic signs; animal-source vitamin | Normal MMA; neural tube defects; heat-labile plant-source vitamin |
| Anti-IF vs anti-parietal cell antibody | Highly specific, confirmatory | Nonspecific, not diagnostically useful |
| Haptocorrin vs transcobalamin | R protein/TC I; binds in stomach; ~75% of plasma Bโโ | Formerly TC II; carries active Bโโ (holoTC) |
| Methylmalonyl CoA mutase vs methionine synthase | Adenosylcobalamin; Bโโ only โ MMA | Methylcobalamin; Bโโ + folate โ homocysteine |
| Serum vs RBC folate | Preferred initial test; fluctuates with diet | Stable, but less validated |
| Pernicious anemia vs hereditary IF deficiency | Autoimmune; atrophic gastritis; achlorhydria | Autosomal recessive; normal histology and acidity |
| Imerslund-Grรคsbeck vs transcobalamin deficiency | Cubilin/amnionless โ ileal uptake fails | Transport protein missing |
| Megaloblastic anemia vs MDS | Responds to vitamins | Vacuoles, budding, multinucleation; refractory |
| Schistocytes here vs microangiopathy | Dyserythropoiesis | Mechanical RBC destruction |
Timeline Table
| Event | Onset | Peak | Duration | Best Exam Use |
|---|---|---|---|---|
| Development (Box 21-4) | 1 โ vitamin levels โ 2 hypersegmented neutrophils โ 3 oval macrocytes โ 4 marrow megaloblastosis โ 5 anemia | โ | Slow โ anemia often severe when detected | Hypersegs appear before anemia |
| Pernicious anemia gastritis | Years to decades | โ | Progressive | Onset usually 6th decade+ |
| Marrow after treatment | Within hours | โ | โ | Revert to normoblastic |
| Retic response | ~1 week | โ | โ | Confirms correct diagnosis |
| Hypersegmented neutrophils | Early in disease | โ | Disappear within 2 weeks of treatment | Earliest and last to leave |
| Hb normalization | โ | ~3 weeks | All parameters 3โ6 weeks | Response monitoring |
| Folate stores vs Bโโ stores* | Folate deficiency develops in months | โ | Bโโ hepatic reserve lasts years | Why Bโโ deficiency develops slowly |
4 ยท Diagnostic Flowcharts
Flowchart 1 โ Macrocytic anemia: megaloblastic or not? (Figure 21-12)
| MCV >100 fL | โ | Look for megaloblastic features: oval macrocytes, hypersegs, pancytopenia |
| No | โ | Nonmegaloblastic: newborn, reticulocytosis, liver disease, alcoholism, marrow failure |
| Yes | โ | Serum Bโโ and folate |
| Bโโ deficiency | โ | Find cause: intake, need, absorption (food, haptocorrin, IF โ PA, H. pylori, gastrectomy), malabsorption, transport, D. latum, blind loop |
| Folate deficiency | โ | Intake, need, absorption, drugs, dialysis |
| No deficiency | โ | MDS, acute erythroid leukemia, CDA, reverse transcriptase inhibitors |
| โ ๏ธ Common mistake: ordering Bโโ/folate for every macrocytosis. A mild MCV of 104 with polychromasia is usually reticulocytosis. | ||
Flowchart 2 โ Interpreting Bโโ and folate levels (Figure 21-10)
| Bโโ <150 pg/mL, folate >4 ng/mL | โ | Bโโ deficiency |
| Bโโ >300, folate <2 ng/mL | โ | Folate deficiency |
| Bโโ >300, folate >4 | โ | Bโโ and folate deficiency unlikely |
| Bโโ 150โ300 and/or folate 2โ4 (borderline) | โ | Measure MMA and homocysteine |
| MMA โ, Hcy N โ Bโโ def ยท MMA โ, Hcy โ โ Bโโ ยฑ folate def ยท MMA N, Hcy โ โ folate def ยท both N โ both excluded | โ | Final classification |
| โ ๏ธ Common mistake: treating a borderline Bโโ as ‘normal’. The 150โ300 pg/mL zone needs MMA and homocysteine. | ||
Flowchart 3 โ Is it pernicious anemia? (Figure 21-11)
| Serum Bโโ <150 pg/mL | โ | Anti-IF blocking antibody |
| Bโโ 150โ300 pg/mL | โ | MMA: >0.4 ยตmol/L โ anti-IF antibody ยท โค0.4 โ not pernicious anemia |
| Bโโ >300 pg/mL | โ | Not pernicious anemia |
| Anti-IF positive | โ | Consistent with pernicious anemia |
| Anti-IF negative | โ | Serum gastrin: >200 pg/mL โ consistent with PA ยท โค200 โ not PA |
| โ ๏ธ Common mistake: ruling out pernicious anemia because anti-IF is negative. About 10% lack detectable antibodies; gastrin helps. | ||
Flowchart 4 โ Timing: development and recovery
| Vitamin levels fall | โ | No blood changes yet |
| Next | โ | Hypersegmented neutrophils appear |
| Then | โ | Oval macrocytes โ marrow megaloblastosis โ anemia |
| After correct treatment | โ | Marrow normalizes in hours; retics โ ~1 week; hypersegs gone in 2 weeks; Hb normal ~3 weeks |
| No response by 1โ2 weeks | โ | Wrong diagnosis (e.g., MDS) or coexisting iron deficiency* |
| โ ๏ธ Common mistake: expecting macrocytosis first. Hypersegmentation often precedes anemia and is the cheapest early screen. | ||
Flowchart 5 โ Test selection for megaloblastic anemia
| Suspected | โ | Screen: CBC, retic, manual differential, bilirubin, LDH |
| Confirm deficiency | โ | Serum Bโโ and folate (fasting); reflex MMA and homocysteine if borderline |
| Bโโ low โ find cause | โ | Anti-IF antibody, serum gastrin (ยฑ gastric analysis); stool O&P for D. latum |
| Vitamins normal, persistent megaloblastosis | โ | Bone marrow (reference confirmatory; look for MDS/erythroleukemia/CDA) |
| Avoid | โ | Anti-parietal cell antibody alone (nonspecific); routine holoTC (low specificity) |
| โ ๏ธ Common mistake: going straight to bone marrow. It confirms megaloblastosis but not the cause. | ||
5 ยท 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | Megaloblastic anemia results from impaired DNA synthesis, most often from vitamin Bโโ or folate deficiency. |
| 2 | All megaloblastic anemias are macrocytic, but not all macrocytic anemias are megaloblastic. |
| 3 | Pernicious anemia is one cause of vitamin Bโโ deficiency and megaloblastic anemia. |
| 4 | Bโโ is the cofactor for methylmalonyl CoA mutase and methionine synthase. |
| 5 | Folate is required to methylate dUMP to dTMP for DNA synthesis. |
| 6 | In Bโโ deficiency, folate is trapped as 5-methyl THF (the folate trap). |
| 7 | RNA and hemoglobin synthesis continue normally, causing nuclearโcytoplasmic asynchrony. |
| 8 | Ineffective hematopoiesis causes pancytopenia with a hypercellular marrow and an M:E ratio near 1:1. |
| 9 | Asynchrony is most striking at the polychromatic normoblast stage. |
| 10 | Giant metamyelocytes and bands are seen in megaloblastic marrow. |
| 11 | MCV ranges from 100 to 150 fL, commonly exceeding 120 fL; MCH is increased and MCHC normal. |
| 12 | The peripheral film shows oval macrocytes and hypersegmented neutrophils. |
| 13 | Hypersegmentation is reported with at least five 5-lobed neutrophils per 100 WBCs or one 6-lobed neutrophil. |
| 14 | Hypersegmented neutrophils appear before anemia and persist up to 2 weeks after treatment. |
| 15 | Intramedullary hemolysis raises indirect bilirubin and LDH. |
| 16 | Methylmalonic acid is increased in Bโโ deficiency but not in folate deficiency. |
| 17 | Homocysteine is increased in both Bโโ and folate deficiency. |
| 18 | Neurologic symptoms from demyelination occur in Bโโ deficiency, sometimes without anemia. |
| 19 | Folate deficiency in early pregnancy can cause neural tube defects. |
| 20 | Intrinsic factor, secreted by gastric parietal cells, is required for ileal absorption of Bโโ via cubam. |
| 21 | Holotranscobalamin is the metabolically active form of vitamin Bโโ. |
| 22 | Pernicious anemia is autoimmune destruction of parietal cells, causing achlorhydria and โ serum gastrin. |
| 23 | Anti-intrinsic factor antibodies are highly specific for pernicious anemia; anti-parietal cell antibodies are not. |
| 24 | Folate is heat labile and plant-derived; Bโโ comes only from animal products and survives cooking. |
| 25 | Folic acid treatment of Bโโ deficiency corrects the anemia but not the neurologic damage. |
MMA splits Bโโ from folate: โ MMA + โ homocysteine = Bโโ deficiency ยท normal MMA + โ homocysteine = folate deficiency. And hypersegmented neutrophils + oval macrocytes + pancytopenia + โ retic + โ LDH/bilirubin = megaloblastic anemia.
Quick Interpretation Table
| Lab Finding | Clinical Interpretation |
|---|---|
| WBC 3.2, Hb 8.5, MCV 121.6, PLT 115, retic 1.8%, hypersegs, oval macrocytes, teardrops | Megaloblastic anemia with inadequate retic response |
| Above + โ Bโโ, N folate, โ MMA | Bโโ deficiency โ test anti-IF antibody (pernicious anemia?) |
| โ Folate, Bโโ 600 pg/mL | Folate deficiency โ MMA expected within reference |
| โ Anti-IF blocking antibody, โ Bโโ | Pernicious anemia |
| Bโโ 220 pg/mL, MMA 0.8 ยตmol/L | Borderline Bโโ with metabolic evidence of deficiency |
| MCV 104, polychromasia, โ retic | Nonmegaloblastic macrocytosis from reticulocytosis |
| Megaloblastoid marrow, normal Bโโ/folate, ring sideroblasts or blasts* | MDS or acute erythroid leukemia |
๐ด Flashcards โ Active Recall Practice
๐ Practice Quiz โ Test Your Knowledge
๐ชค Trap Questions โ Beat the Examiner
8 ยท Rapid Revision Sheet
CBC & Film
- MCV 100โ150 (often >120) ยท MCH โ ยท MCHC N ยท RDW โ
- Pancytopenia ยท โ retic ยท no polychromasia
- Oval macrocytes ยท hypersegs ยท teardrops
- HJ bodies, stippling, Cabot rings, nRBCs
- โ indirect bili, โ LDH
Hypersegs
- โฅ5 five-lobed / 100 WBC
- or โฅ1 six-lobed
- Mean lobe count >3.4
- Appear before anemia
- Gone within 2 weeks of therapy
Marrow
- Hypercellular ยท M:E ~1:1
- Asynchrony: nucleus lags cytoplasm
- Most striking at polychromatic stage
- Giant metamyelocytes/bands
- Megakaryocytes inconsistent
Biochemistry
- MMA โ = Bโโ only (mutase)
- Homocysteine โ = Bโโ or folate (synthase)
- Folate trap = 5-methyl THF stuck
- dUMP โ dTMP (thymidylate synthase)
- Methotrexate blocks DHFR โ leucovorin
Bโโ Absorption
- Acid + pepsin โ haptocorrin (R)
- IF from parietal cells
- Trypsin frees โ IFโBโโ
- Ileal cubam (cubilinโamnionless)
- Transcobalamin โ holoTC (10โ30%, active)
Pernicious Anemia
- Autoimmune CD4 vs Hโบ/Kโบ-ATPase
- Atrophic gastritis ยท achlorhydria ยท โ gastrin
- Anti-IF ~90%, specific ยท anti-parietal ~90%, nonspecific
- ~25/100,000 >40 y ยท 6th decade+
- Lifelong IM (or high oral) Bโโ
Algorithm Cutoffs
- Bโโ <150 = deficient ยท 150โ300 borderline ยท >300 OK
- Folate <2 = deficient ยท 2โ4 borderline ยท >4 OK
- Borderline โ MMA + homocysteine
- PA: MMA >0.4 ยตmol/L โ anti-IF
- Anti-IF neg โ gastrin >200 pg/mL = PA
Opposites
- Bโโ: neuro, animal foods, survives cooking, liver reserve
- Folate: neural tube, plants, heat labile
- Megaloblastic MCV >120 vs nonmegaloblastic 100โ110
- Anti-IF specific vs anti-parietal nonspecific
Causes
- Folate drugs: MTX, 5-FU, hydroxyurea, phenytoin, TMP, pyrimethamine, pentamidine
- Folate loss: dialysis
- Bโโ: vegans, PPIs/Hโ blockers, H. pylori, gastrectomy
- D. latum, blind loop, Imerslund-Grรคsbeck
- Non-vitamin: MDS, M6, CDA, RT inhibitors
False Results & Response
- False โ Bโโ: pregnancy, folate def, myeloma, HIV, vit C
- False โ Bโโ: liver dz, MPN, malignancy, anti-IF titer
- False โ folate: recent meal
- Retic ~1 wk ยท Hb ~3 wk ยท all 3โ6 wk
- Folic acid alone won’t fix Bโโ neuropathy
9 ยท Final Memory Map
- ๐งฌ DEFECTS OF DNA METABOLISM
- Classification
- Macrocytic โ megaloblastic โ pernicious
- Megaloblastic: folate, Bโโ, MDS/M6/CDA/drugs
- Nonmegaloblastic: newborn, retics, liver, alcohol, marrow failure
- Biochemistry
- Bโโ: mutase (MMA) + methionine synthase (Hcy)
- Folate: dUMP โ dTMP
- Folate trap ยท uridine in DNA โ breaks โ apoptosis
- Pathology
- Asynchrony ยท megaloblasts ยท giant bands
- Ineffective hematopoiesis โ pancytopenia, โ bili/LDH
- Clinical
- Anemia, glossitis, GI symptoms
- Bโโ: demyelination, neuropsychiatric
- Folate: neural tube defects
- Causes
- Folate: intake, need, absorption, drugs, dialysis
- Bโโ: intake (vegans), need, absorption (food, haptocorrin, IF, malabsorption, transport), competition
- Bโโ Absorption & PA
- Haptocorrin โ IF โ cubam โ transcobalamin โ holoTC
- PA: autoimmune, achlorhydria, โ gastrin, anti-IF
- Laboratory
- Screen: CBC, retic, diff, bilirubin, LDH
- Specific: Bโโ, folate, MMA, Hcy, antibodies, gastrin
- Algorithms and false results
- Treatment
- Specific vitamin + treat cause
- Lifelong Bโโ in PA
- Response: hours โ 1 wk โ 3 wk
- Classification